Discovery of YYSW001: A Highly Selective, Orally Bioavailable JAK1 Inhibitor Achieving Efficacy under a Moderate-Inhibition Strategy with Improved Preclinical Tolerability
用户6X7Ch8WUQ_gI
1个月前
75
10
已完结
1. 系统已在2026-03-29 13:12:05对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c03183
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c03183
其他信息:
出版社: American Chemical Society (ACS)
作者: Kaiyong Hu; Yezhi Wang; Pengfei Xu; Tian Jing; Xinying Cheng; Pei Shen; Baoxin Wang; Kang Fu; Min Zhang; Mingjing Gao; Zhiyu Li; Jubo Wang; Zhixia Qiu; Jinlei Bian
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03183
